How Ozempic Is Changing Thanksgiving
Thanks to the GLP-1 revolution, families across the country are negotiating new ways to connect over the holidays.
Factor in Eli Lilly weight-loss drug could help treat certain eating disorders, study finds
Researchers reported that Eli Lilly’s GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the “reward center” of the brain.
The surprising new use for GLP-1s: Alcohol and drug addiction – The Washington Post
The surprising new use for GLP-1s: Alcohol and drug addiction The Washington Post Taking Ozempic? Yale Researchers Say You’ll Handle Alcohol “Differently” and It Could Be Risky SciTechDaily Doctor finds new use for GLP-1s: Alcohol, drug addiction NewsNation Opinion | Do you take a GLP-1 for alternative uses? Tell us about it. The New York Times The ‘magic’ medicine: […]
Vanda’s tradipitant can significantly reduce nausea in those taking a GLP-1
High-Protein Snacks for GLP-1 Users
You might recognize this scene. Lunch was small, you feel full sooner than usual, and by late afternoon you are both a little hungry and a little uninterested in a full plate. That’s a common GLP-1 experience. One trick is to keep a short list of satisfying, easy snacks that slip into your day and […]
The ‘magic’ medicine: Can weight-loss drug GLP-1 treat alcohol and drug addiction?
Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging research suggests these medications can dampen cravings for alcohol and drugs by influencing the brain’s reward system. While still in early stages, clinical trials and early patient experiences indicate a significant new therapeutic avenue for addiction treatment, offering hope […]
Novo Nordisk Rolls Out $349 Wegovy Cash Price Ahead Of Plan
Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ahead of the timeline set out with the Trump… Reuters Health Information
Healthcare, Vol. 13, Pages 2958: Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence
Healthcare, Vol. 13, Pages 2958: Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence Healthcare doi: 10.3390/healthcare13222958 Authors: Cristina Ștefănescu Elena Alexandra Bratu Ana Maria Pelin Denisa Boroi Bianca Daniela Crecan-Suciu Victorița Ștefănescu Objective: This is the first umbrella review to integrate the available research syntheses on the associations between glucagon-like peptide-1 […]
A case study on cravings and a GLP-1
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. As a reminder, STAT’s Isabella Cueto and J. Emory Parker are keeping track of every promise made by health secretary Robert F. Kennedy Jr. about reworking American health care. They just updated their tracker with […]
The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company
Eli Lilly shares have room to keep rising as GLP-1 drugs spread reach The trillion-dollar club has become crowded with mostly tech names riding the AI boom. Eli LillyLLY-0.35%decrease; red down pointing triangle might soon join them for a far different reason: the weight-loss bonanza. Crucially, …